Business Context and Reporting Period
This Form 8-K is filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) for the reporting period ending December 1, 2015. The filing reports on executive compensation arrangements and the adoption of a new equity incentive plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and executive compensation events.
Material Changes
- Executive Appointment and Compensation: On December 1, 2015, the Board approved the grant of 190,000 inducement restricted stock units (RSUs) to Will McGuire, the Company's Chief Executive Officer.
- Vesting Schedule: The award vests over four years. 25% vests on August 18, 2016 (the first anniversary of employment), with the remainder vesting in twelve equal quarterly installments of 6.25%.
- Regulatory Compliance: The grant was made as an inducement material to Mr. McGuire's acceptance of employment, in accordance with NASDAQ Listing Rule 5635(c)(4).
- New Plan Adoption: The Company adopted the "Second Sight Medical Products, Inc. Equity Incentive Plan – Restricted Stock Units" and the corresponding Award Agreement to facilitate this grant.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, or specific risk factors beyond the standard vesting condition requiring Mr. McGuire's continuous service through each vesting date. A press release regarding this grant was issued on December 4, 2015.
Investor Verification Checklist
- Verify the total number of RSUs granted (190,000) and the specific vesting schedule details.
- Confirm the adoption of the new Equity Incentive Plan via the attached Exhibits 10.1 and 10.2.
- Review the press release (Exhibit 99.1) for additional context on the CEO's appointment.
- Note that this filing contains no financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.